Comparative Pharmacology
Head-to-head clinical analysis: TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT versus TECHNETIUM TC 99M MERTIATIDE KIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT versus TECHNETIUM TC 99M MERTIATIDE KIT.
TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT vs TECHNETIUM TC 99M MERTIATIDE KIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Technetium Tc 99m albumin aggregated is a radiopharmaceutical that localizes in the pulmonary capillary bed by capillary blockade, allowing for lung perfusion imaging. The aggregated albumin particles are trapped in the pulmonary capillaries, and the Tc 99m emits gamma radiation detectable by gamma cameras.
Technetium Tc 99m mertiatide is a radiopharmaceutical diagnostic agent that undergoes renal tubular secretion and glomerular filtration, allowing for dynamic imaging of renal function and urinary tract patency.
1-4 mCi (37-148 MBq) intravenous injection for lung perfusion imaging. Single dose per imaging session.
1-10 mCi (37-370 MBq) intravenously as a single dose for renal imaging.
None Documented
None Documented
Physical half-life of Tc-99m is 6.02 hours; biological half-life of aggregated albumin in lungs is 2-4 hours due to enzymatic degradation and clearance.
Terminal elimination half-life: approximately 1.5–2 hours for the non-protein-bound fraction; allows rapid imaging within 30 minutes and clearance from blood pool.
Renal: 30-40% within 24 hours (free pertechnetate); fecal: <1% (minor); remainder accumulated in reticuloendothelial system with slow release.
Renal: approximately 50% excreted unchanged in urine within 2 hours; 70% within 24 hours. Biliary/fecal: negligible.
Category C
Category C
Diagnostic Radiopharmaceutical
Diagnostic Radiopharmaceutical